Maravai LifeSciences Holdings, Inc. (MRVI)
USD 5.58
(-3.88%)
USD 5.58
(-3.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 126.22 Million | 535.97 Million | 368.57 Million | 152.18 Million | 24.11 Million | -186 Thousand |
| Net Income | -119.02 Million | 490.66 Million | 469.25 Million | 78.81 Million | -5.2 Million | -16.91 Million |
| Depreciation & Amortization | 48.78 Million | 38.1 Million | 24.75 Million | 25.83 Million | 24.08 Million | 22.34 Million |
| Deferred income taxes | 754.94 Million | 42.31 Million | 46.9 Million | -5.46 Million | -1.15 Million | 317 Thousand |
| Stock-based compensation | 34.58 Million | 18.67 Million | 10.45 Million | 24.62 Million | 1.67 Million | 2.12 Million |
| Change in working capital | 97.84 Million | -45.08 Million | -176.63 Million | 35.89 Million | 2.29 Million | -15.84 Million |
| Other non-cash items | -690.9 Million | -8.69 Million | -6.16 Million | -7.52 Million | 2.42 Million | 7.78 Million |
| Investing Cash Flow | -122.31 Million | -267.61 Million | 105.65 Million | 6.06 Million | -17.14 Million | -3.45 Million |
| Investments in PPE | -65.55 Million | -17.09 Million | -14.85 Million | -25.4 Million | -17.14 Million | -3.61 Million |
| Acquisitions | -69.62 Million | -238.34 Million | 119.95 Million | -3.02 Million | - | 160 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 12.86 Million | -12.17 Million | 548 Thousand | 34.5 Million | - | 160 Thousand |
| Financing Cash Flow | -61.09 Million | -187.49 Million | -159.04 Million | 53.21 Million | -4.16 Million | -9.16 Million |
| Debt repayment | -5.77 Million | -13.89 Million | -6 Million | -412.07 Million | -2.64 Million | -255.2 Million |
| Dividends payments | - | - | - | - | - | -52.05 Million |
| Common Stock Repurchased | -20 Thousand | - | - | -1.45 Billion | -227 Thousand | -9000.00 |
| Common Stock Issuance | -20 Thousand | 2.35 Million | 1.7 Million | 1.75 Billion | - | - |
| Other Financing Activities | -55.29 Million | -175.96 Million | -154.75 Million | 773.65 Million | -1.3 Million | 298.09 Million |
| Accounts receivables | 84.39 Million | -22.27 Million | -70.39 Million | -33.14 Million | -1.88 Million | -4.14 Million |
| Accounts payables | 5.28 Million | -1.57 Million | 676 Thousand | 1.17 Million | 2.47 Million | -871 Thousand |
| Inventory | 649 Thousand | 9.45 Million | -21.57 Million | -19.09 Million | 106 Thousand | 2.31 Million |
| Other working capital | 7.51 Million | -30.69 Million | -85.34 Million | 86.96 Million | 1.6 Million | -13.13 Million |
| Cash at beginning of period | 632.13 Million | 551.27 Million | 236.18 Million | 24.7 Million | 21.86 Million | 34.73 Million |
| Cash at end of period | 574.96 Million | 632.13 Million | 551.27 Million | 236.18 Million | 24.7 Million | 21.86 Million |
| Capital Expenditure | -65.55 Million | -17.09 Million | -14.85 Million | -25.4 Million | -17.14 Million | -3.61 Million |
| Effect of forex changes on cash | 1.61 Million | - | -88 Thousand | 17 Thousand | 34 Thousand | -69 Thousand |
| Net cash flow / Change in cash | -57.17 Million | 80.86 Million | 315.08 Million | 211.48 Million | 2.83 Million | -12.87 Million |
| Free Cash Flow | 60.67 Million | 518.88 Million | 353.72 Million | 126.77 Million | 6.96 Million | -3.79 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.58 Million | -12.07 Million | -119.02 Million | -105.95 Million | -6.46 Million | -11.94 Million |
| Depreciation & Amortization | 14.54 Million | 13.75 Million | 48.78 Million | 12.98 Million | 13.09 Million | 11.79 Million |
| Deferred income taxes | - | - | 754.94 Million | 764.75 Million | -5.53 Million | -2.75 Million |
| Stock-based compensation | 13.76 Million | 12.05 Million | 34.58 Million | 9.34 Million | 9.98 Million | 9.27 Million |
| Change in working capital | 2.24 Million | -10.64 Million | 97.84 Million | 2.37 Million | 8.57 Million | 18.55 Million |
| Other non-cash items | 34.02 Million | 12.98 Million | -690.9 Million | -675.7 Million | -5.49 Million | -5.72 Million |
| Investing Cash Flow | -6.18 Million | -4.24 Million | -122.31 Million | -12.9 Million | -15.52 Million | -24.15 Million |
| Investments in PPE | -9.55 Million | -5.66 Million | -65.55 Million | -16.79 Million | -15.82 Million | -25.05 Million |
| Acquisitions | - | - | -69.62 Million | 74.91 Million | - | 109 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 3.37 Million | 1.42 Million | 12.86 Million | 3.89 Million | 307 Thousand | 793 Thousand |
| Financing Cash Flow | 228 Thousand | -560 Thousand | -61.09 Million | 470 Thousand | 783 Thousand | -43.13 Million |
| Debt repayment | -1.5 Million | -1.5 Million | -5.77 Million | -1.5 Million | -1.48 Million | -1.42 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -28 Thousand | -1.43 Million | -20 Thousand | -351 Thousand | - | - |
| Common Stock Issuance | - | -1.43 Million | -20 Thousand | -20 Thousand | - | - |
| Other Financing Activities | 1.73 Million | 945 Thousand | -55.29 Million | 1.99 Million | 2.26 Million | -41.7 Million |
| Accounts receivables | -2.02 Million | 17.88 Million | 84.39 Million | -8.78 Million | 3.21 Million | 7.56 Million |
| Accounts payables | 4.57 Million | -3.68 Million | 5.28 Million | 1.65 Million | 1.98 Million | 1.87 Million |
| Inventory | 751 Thousand | 820 Thousand | 649 Thousand | -2.18 Million | -1.49 Million | 7.71 Million |
| Other working capital | -1.05 Million | -25.66 Million | 7.51 Million | 11.68 Million | 4.86 Million | 1.4 Million |
| Cash at beginning of period | 561.69 Million | 574.96 Million | 632.13 Million | 579.6 Million | 580.17 Million | 628.27 Million |
| Cash at end of period | 573.17 Million | 561.69 Million | 574.96 Million | 574.96 Million | 579.6 Million | 580.17 Million |
| Capital Expenditure | -9.55 Million | -5.66 Million | -65.55 Million | -16.79 Million | -15.82 Million | -25.05 Million |
| Effect of forex changes on cash | - | - | 1.61 Million | - | - | - |
| Net cash flow / Change in cash | 11.48 Million | -13.27 Million | -57.17 Million | -4.64 Million | -571 Thousand | -48.09 Million |
| Free Cash Flow | 7.88 Million | -14.13 Million | 60.67 Million | -9 Million | -1.66 Million | -5.86 Million |
300823
0KXA
OPCE
PCTN
300539
6069